Literature DB >> 18178196

Follicle-stimulating hormone receptor and DAZL gene polymorphisms do not affect the age of menopause.

Irene Zerbetto1, Jörg Gromoll, Stefano Luisi, Fernando M Reis, Eberhard Nieschlag, Manuela Simoni, Felice Petraglia.   

Abstract

OBJECTIVE: To evaluate whether single nucleotide FSH receptor and DAZL gene polymorphisms are associated with menarche and menopause timing.
DESIGN: Prospective study.
SETTING: Siena and Münster Universities. PATIENT(S): Physiologically menopausal women. INTERVENTION(S): The presence of FSH receptor or DAZL gene polymorphisms was investigated. Blood samples were collected and polymorphisms evaluated in extracted genomic DNA. MAIN OUTCOME MEASURE(S): Menarche age, menopausal age, and total years of fertility were evaluated on the basis of FSH receptor (genotypes Asn/Asn, Asn/Ser, and Ser/Ser at codon 680) and DAZL gene. RESULT(S): The median age of menarche was 13 years in the Asn/Asn group and 12 years in the Asn/Ser and Ser/Ser groups. The median age at menopause was 50 years in the Asn/Asn and Asn/Ser groups and 51 years in the Ser/Ser group. The length of the fertile period was 37 years in the Asn/Asn group, 38 years in the Asn/Ser group, and 39 years in the Ser/Ser group. Regarding the DAZL polymorphism, A/A, A/G, and G/G had the same age at menarche, age at menopause, and length of fertile period. CONCLUSION(S): We found that genotype of FSH receptor or SNP of DAZL do not predict the age at natural menopause and duration of fertility in women. The presence of Asn680/Asn680 genotype is associated with a slightly delayed age at menarche.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178196     DOI: 10.1016/j.fertnstert.2007.10.036

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

Review 1.  Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.

Authors:  Livio Casarini; Elisa Pignatti; Manuela Simoni
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

Review 2.  Genomic markers of ovarian reserve.

Authors:  Michelle A Wood; Aleksandar Rajkovic
Journal:  Semin Reprod Med       Date:  2013-10-07       Impact factor: 1.303

3.  RNA immunoprecipitation identifies novel targets of DAZL in human foetal ovary.

Authors:  Roseanne Rosario; Richard W P Smith; Ian R Adams; Richard A Anderson
Journal:  Mol Hum Reprod       Date:  2017-03-01       Impact factor: 4.025

Review 4.  Women's reproductive span: a systematic scoping review.

Authors:  A F Nabhan; G Mburu; F Elshafeey; R Magdi; M Kamel; M Elshebiny; Y G Abuelnaga; M Ghonim; M H Abdelhamid; Mo Ghonim; P Eid; A Morsy; M Nasser; N Abdelwahab; F Elhayatmy; A A Hussein; N Elgabaly; E Sawires; Y Tarkhan; Y Doas; N Farrag; A Amir; M F Gobran; M Maged; M Abdulhady; Y Sherif; M Dyab; J Kiarie
Journal:  Hum Reprod Open       Date:  2022-02-11

5.  Dazl determines primordial follicle formation through the translational regulation of Tex14.

Authors:  Roseanne Rosario; James H Crichton; Hazel L Stewart; Andrew J Childs; Ian R Adams; Richard A Anderson
Journal:  FASEB J       Date:  2019-10-26       Impact factor: 5.834

6.  Is there a role for DAZL in human female fertility?

Authors:  Roseanne Rosario; Ian R Adams; Richard A Anderson
Journal:  Mol Hum Reprod       Date:  2016-03-16       Impact factor: 4.025

Review 7.  RNA-binding proteins in human oogenesis: Balancing differentiation and self-renewal in the female fetal germline.

Authors:  Roseanne Rosario; Andrew J Childs; Richard A Anderson
Journal:  Stem Cell Res       Date:  2017-04-18       Impact factor: 2.020

8.  RANKL is a new Epigenetic Biomarker for the Vasomotor Symptom During Menopause.

Authors:  R Kalkan; M Altarda; O Tosun
Journal:  Balkan J Med Genet       Date:  2020-08-26       Impact factor: 0.519

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.